stella
beta
Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease — Stella
Recruiting
Back to Steroid Refractory GVHD trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(11 sites)
United States
Site 1091, Duarte, California
Site 1343, Los Angeles, California
Site 1318, Atlanta, Georgia
Site 1068, St Louis, Missouri
Site 1100, Cincinnati, Ohio
Show all 11 locations
View full record on ClinicalTrials.gov